Trastuzumab deruxtecan是一款靶向HER2的抗体偶联药物(ADC)，用于此前接受过两种或两种以上抗HER2治-疗的HER2阳性转移性乳腺癌患者。
货号（Catalog No.）
CSD00487
通用名INN
Trastuzumab Deruxtecan
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
产品描述(Description)
Trastuzumab deruxtecan是一款靶向HER2的抗体偶联药物(ADC)，用于此前接受过两种或两种以上抗HER2治-疗的HER2阳性转移性乳腺癌患者。
别名(Alternative names)
DS-8201,DS-8201a
靶点;物种(Specificity target name;species)
ERBB2/EGFR2/CD340[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa